Real-time enrollment status for this hyperphosphatemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06933472 |
| Recruiting Status | Recruiting |
| Condition | Hyperphosphatemia |
| Phase | Clinical Trial |
| Target Enrollment | 264 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Alebund Pharmaceuticals |
| Last Updated on CT.gov | January 29, 2026 (Jan 29, 2026) |
As of March 2, 2026: Clinical trial NCT06933472 is currently recruiting participants. This clinical trial study for hyperphosphatemia is actively seeking new participants at 9 locations across the United States. The study is sponsored by Alebund Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06933472 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06933472 was last updated Jan 29, 2026 (January 29, 2026). HelloStudys verifies this status automatically.